Archived Press Releases
The news releases presented here were believed to be accurate at the time they were issued and are provided for historical reference purposes only. They contain information that may no longer be accurate. Readers should not rely on the continued accuracy of any such material. All readers should carefully check the dates of issuance of the releases. NeurogesX assumes no obligation and does not intend to update, correct or otherwise modify any of these press releases regarding events that occur after their original release.
- October 20, 2003
NeurogesX Appoints Stephen Ghiglieri as Chief Financial Officer - October 8, 2003
NeurogesX Launches Multi-Center Study for Painful HIV-Associated Neuropathy - September 3, 2003
NeurogesX Appoints Thorsten von Stein MD. PhD. as Chief Medical Officer - August 7, 2003
NeurogesX Names Anthony DiTonno as CEO - April 2, 2003
Significant Pain Reduction for Post-Shingles Patients Demonstrated in Phase II Study
